Vemurafenib Active Not Recruiting Phase 1 / 2 Trials for Melanoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01657591Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma
NCT01943422Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma